OxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1

Journal of Molecular Endocrinology

Volumn 53, Issue 2, 2014, Pages 281-293

  Zhang, Qi ^a   Liu, Jing ^b   Liu, Jia ^b   Huang, Wenhui ^b   Tian, Limin ^b   Quan, Jinxing ^b   Wang, Yunfang ^b   Niu, Ruilan ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Defenestration; Endothelial injury; Human liver sinusoidal endothelial cells; Lectin like oxLDL receptor 1; Oxidised LDL

Indexed keywords

CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; CD31 ANTIGEN; LOW DENSITY LIPOPROTEIN; OLR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CELL STRUCTURE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; CYTOTOXICITY; DEFENESTRATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN LIVER SINUSOIDAL ENDOTHELIAL CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER SINUSOID; MIDDLE AGED; POROSITY; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; RNA INTERFERENCE; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANTIGENS, CD31; CAVEOLIN 1; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; LIVER; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E;

EID: 84907970446     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0049     Document Type: Article

References (71)

1. Ballinger SW 2005 Mitochondrial dysfunction in cardiovascular disease. Free Radical Biology & Medicine 38 1278-1295. (doi:10.1016/j.freeradbiomed.2005.02.014)
2. Braet F & Wisse E 2002 Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comparative Hepatology 1 1. (doi:10.1186/1476-5926-1-1)
3. Braet F, De Zanger R, Baekeland M, Crabbe´ E, Van Der Smissen P & Wisse E 1995 Structure and dynamics of the fenestrae-associated cytoskeleton of rat liver sinusoidal endothelial cells. Hepatology 21 180-189. (doi:10.1016/0270-9139(95)90427-1)
4. Braet F, Vanbesien J, De Zanger R & Wisse E 2002 Ageing of the liver sieve and pseudocapillarisation. Lancet 360 1171-1172. (doi:10.1016/S0140-6736(02)11214-1)
5. Braet F, Muller M, Vekemans K, Wisse E & Le Couteur DG 2003 Antimycin A-induced defenestration in rat hepatic sinusoidal endothelial cells. Hepatology 38 394-402. (doi:10.1053/jhep.2003.50347)
6. Cameron JD & Cruickshank JK 2007 Glucose, insulin, diabetes and mechanismsof arterialdysfunction.Clinical andExperimentalPharmacology & Physiology 34 677-682. (doi:10.1111/j.1440-1681.2007.04659.x)
7. Channon KM 2004 Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends in Cardiovascular Medicine 14 323-327. (doi:10.1016/j.tcm.2004.10.003)
8. Chen WL, Qian Y, Meng WF, Pang JY, Lin YC, Guan YY, Chen SP, Liu J, Pei Z & Wang GL 2009 A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochemical Pharmacology 78 941-950. (doi:10.1016/j.bcp.2009.05.029)
9. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V & Sawamura T 2000 Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. Journal of Biological Chemistry 275 12633-12638. (doi:10.1074/jbc.275.17.12633)
10. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio U & Sawamura T 2001 The binding of oxidized lowdensity lipoprotein (oxLDL) to ox-LDL receptor-1 in endothelial cells reduces the intracellular concentration of nitric oxide through an increased production of superoxide. Journal of Biological Chemistry 276 13750-13755. (doi:10.1074/jbc.M010612200)
11. Daneker GW, Lund SA, Caughman SW, Swerlick RA, Fischer AH, Staley CA & Ades EW 1998 Culture and characterization of sinusoidal endothelial cells isolated from human liver. In Vitro Cellular & Developmental Biology. Animal 34 370-377. (doi:10.1007/s11626-998-0018-9)
12. Dobbs BR, Rogers GW, Xing HY & Fraser R 1994 Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis? Liver 14 230-233. (doi:10.1111/j.1600-0676.1994.tb00080.x)
13. Dorman RB, Wunder C, Saba H, Shoemaker JL, MacMillan-Crow LA & Brock RW 2006 NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. American Journal of Physiology. Gastrointestinal and Liver Physiology 290 G1025-G1032. (doi:10.1152/ajpgi.00246.2005)
14. Doughan AK, Harrison DG & Dikalov SI 2008 Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation Research 102 488-496. (doi:10.1161/CIRCRESAHA.107.162800)
15. El-Serag HB, Tran T & Everhart JE 2004 Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 460-468. (doi:10.1053/j.gastro.2003.10.065)
16. Farrell GC, Teoh NC & McCuskey RS 2008 Hepaticmicrocirculation in fatty liver disease. Anatomical Record 291 684-692. (doi:10.1002/ar.20715)
17. Fleming I, Mohamed A, Galle J, Turchanowa L, Brandes RP, Fisslthaler B & Busse R 2005 Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCa. Cardiovascular Research 65 897-906. (doi:10.1016/j.cardiores.2004.11.003)
18. Fraser R, Cogger VC, Dobbs B, Jamieson H, Warren A, Hilmer SN & Le Couteur DG 2012 The liver sieve and atherosclerosis. Pathology 44 181-186. (doi:10.1097/PAT.0b013e328351bcc8)
19. 2K formation. Nephrology, Dialysis, Transplantation 15 339-346. (doi:10.1093/ndt/15.3.339)
20. Galle J, Hansen-Hagge T, Wanner C & Seibold S 2006 Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185 219-226. (doi:10.1016/j.atherosclerosis.2005.10.005)
21. Hamilton SJ & Watts GF 2013 Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Review of Diabetic Studies 10 133-156. (doi:10.1900/RDS.2013.10.133)
22. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A et al. 2001 Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research 13 E14-E22. (doi:10.1161/01.RES.88.2.e14)
23. Holvoet P, De Keyzer D & Jacobs DR 2008 Oxidized LDL and the metabolic syndrome. Future Lipidology 3 637-649. (doi:10.2217/17460875.3.6.637)
24. Hudacko RM, Sciancalepore JP & Fyfe BS 2009 Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications. American Journal of Clinical Pathology 132 494-499. (doi:10.1309/AJCPQBFF42ZZXXRQ)
25. Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, Minami M, Kita T, Shiomi M & Saji H 2007 Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability-analysis in hypercholesterolemic rabbits. Atherosclerosis 195 48-56. (doi:10.1016/j.atherosclerosis.2006.11.031)
26. Kalani M 2008 The importance of endothelin-1 for microvascular dysfunction in diabetes. Vascular Health and Risk Management 4 1061-1068.
27. Kauser K, da Cunha V, Fitch R, Mallari C & Rubanyi GM 2000 Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. American Journal of Physiology. Heart and Circulatory Physiology 278 H1679-H1685.
28. Kohan DE, Rossi NF, Inscho EW & Pollock DM 2011 Regulation of blood pressure and salt homeostasis by endothelin. Physiological Reviews 91 71-77. (doi:10.1152/physrev.00060.2009)
29. Krishnan B, Babu S, Walker J, Walker AB & Pappachan JM 2013 Gastrointestinal complications of diabetes mellitus. World Journal of Diabetes 4 51-63. (doi:10.4239/wjd.v4.i3.51)
30. Le Couteur DG, Fraser R, Cogger VC & McLean AJ 2002 Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 359 1612-1615. (doi:10.1016/S0140-6736(02)08524-0)
31. Li D & Mehta JL 2000 Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arteriosclerosis, Thrombosis, and Vascular Biology 20 1116-1122. (doi:10.1161/01.ATV.20.4.1116)
32. Li L, Chu Y, Fink GD, Engelhardt JF, Heistad DD & Chen AF 2003 Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 42 (5) 997-1003. (doi:10.1161/01.HYP.0000095980.43859.59)
33. Li R, Oteiza A, Sørensen KK, McCourt P, Olsen R, Smedsrød B & Svistounov D 2011 Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins. American Journal of Physiology. Gastrointestinal and Liver Physiology 300 71-81. (doi:10.1152/ajpgi.00215.2010)
34. Little PJ, Ivey ME & Osman N 2008 Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Current Vascular Pharmacology 6 195-203. (doi:10.2174/157016108784911966)
35. Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ & Forrest KY 1999 Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clinical Immunology 90 165-172. (doi:10.1006/clim.1998.4631)
36. Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX & Zheng M 2013 Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World Journal of Gastroenterology 19 3134-3142. (doi:10.3748/wjg.v19.i20.3134)
37. Ma Y, Liu J, Li P, Zhu S & Lin C 2012 Effects of serum containing Tanyu Tongzhi formula on production of NO, caveolin-1 and eNOS in HUVECs injured by ox-LDL. Zhongguo Zhong Yao Za Zhi 37 974-978.
38. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L & Maziere JC 1996 Oxidized low density lipoprotein induces activation of the transcription factor NFκB in fibroblasts, endothelial and smooth muscle cells. IUBMB Life 39 1201-1207. (doi:10.1080/15216549600201392)
39. McCuskey RS 2006 Sinusoidal endothelial cells as an early target for hepatic toxicants. Clinical Hemorheology and Microcirculation 34 5-10.
40. Mehta JL, Chen J, Hermonat PL, Romeo F & Novelli G 2006 Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovascular Research 69 4536-4544. (doi:10.1016/j.cardiores.2005.09.006)
41. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K et al. 2007 Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circulation Research 100 1634-1642. (doi:10.1161/CIRCRESAHA.107.149724)
42. Mertens A & Holvoet P 2011 Oxidized LDL and HDL:antagonists in atherothrombosis. FASEB Journal 15 2073-2084. (doi:10.1096/fj.01-0273rev)
43. Mohamed MR & McFadden G 2009 NFκB inhibitors: strategies from poxviruses. Cell Cycle 8 3125-3132. (doi:10.4161/cc.8.19.9683)
44. Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T & Holtz J 2001 Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells. Biochemical and Biophysical Research Communications 284 (4) 961-965. (doi:10.1006/bbrc.2001.5044)
45. Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T & Holtz J 2002 Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1. Clinical Science 103 (Suppl 48) 9-12.
46. Ogi M, Yokomori H, Oda M, Yoshimura K, Nomura M, Ohshima S, Akita M, Toda K & Ishii H 2003 Distribution and localization of caveolin-1 in sinusoidal cells in rat liver. Medical Electron Microscopy 36 33-40. (doi:10.1007/s007950300004)
47. Oishi P, Azakie A, Harmon C, Fitzgerald RK, Grobe A, Xu J, Hendricks-Munoz K, Black SM & Fineman JR 2006 Nitric oxideendothelin-1 interactions after surgically induced acute increases in pulmonary blood flow in intact lambs. American Journal of Physiology. Heart and Circulatory Physiology 290 1922-1932. (doi:10.1152/ajpheart.01091.2005)
48. Oteiza A, Li R, McCuskey RS, Smedsrød B & Sørensen KK 2011 Effects of oxidized low-density lipoproteins on the hepatic microvasculature. American Journal of Physiology. Gastrointestinal and Liver Physiology 301 684-693. (doi:10.1152/ajpgi.00347)
49. Pasarín M, La Mura V, Gracia-Sancho J, García-Caldero´ H, Rodríguez-Vilarrupla A, García-Paga´n JC, Bosch J & Abraldes JG 2012 Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS ONE 7 e32785. (doi:10.1371/journal.pone.0032785)
50. Pirillo A, Norata GD & Catapano AL 2013 LOX-1, OxLDL, and atherosclerosis. Mediators of Inflammation 2013 152786. (doi:10.1155/2013/152786)
51. Rautureau Y & Schiffrin EL 2012 Endothelin in hypertension: an update. Current Opinion in Nephrology and Hypertension 21 128-136. (doi:10.1097/MNH.0b013e32834f0092)
52. Renier G, Maingrette F & Li L 2007 Diabetic vasculopathy and the lectinlike oxidized low-density lipoprotein receptor-1 (LOX-1). Current Diabetes Reviews 3 103-110. (doi:10.2174/157339907780598225)
53. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T et al. 1997 An endothelial receptor for oxidized low-density lipoprotein. Nature 386 73-77. (doi:10.1038/386073a0)
54. Steinberg D 1997 Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 272 20963-20966. (doi:10.1074/jbc.272.34.20963)
55. Sun SW, Zu XY, Tuo QH, Chen LX, Lei XY, Li K, Tang CK & Liao DF 2010 Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacologica Sinica 31 1336-1342. (doi:10.1038/aps.2010.87)
56. Truong TQ, Brodeur MR, Falstrault L, Rhainds D & Brissette L 2009 Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors. Journal of Cellular Biochemistry 108 906-915. (doi:10.1002/jcb.22321)
57. Venkatraman L & Tucker-Kellogg L 2013 The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells. Liver International 33 1386-1397. (doi:10.1111/liv.12231)
58. Walenbergh SM, Koek GH, Bieghs V & Shiri-Sverdlov R 2013 Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. Hepatology 58 801-810. (doi:10.1016/j.jhep.2012.11.014)
59. Wang BY, Ju XH, Fu BY, Zhang J & Cao YX 2005 Effects of ethanol on liver sinusoidal endothelial cells-fenestrae of rats. Hepatobiliary & Pancreatic Diseases International 4 422-426.
60. Witztum JL & Steinberg D 2001 The oxidative modification hypothesis of atherosclerosis: does it hold forhumans? Trends in Cardiovascular Medicine 11 93-102. (doi:10.1016/S1050-1738(01)00111-6)
61. Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hübschle T, Mang C, Strobel H, Suzuki T, Kleinert H et al. 2008 Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitricoxide synthase (eNOS) expression and preventing eNOS uncoupling. Journal of Phamacology and Experimental Therapeutics 325 370-379. (doi:10.1124/jpet.107.128009)
62. Wu CC, Wang SH, Kuan II, Tseng WK, Chen MF, Wu JC & Chen YL 2009 OxLDL upregulates caveolin-1 expression in macrophages: role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. Journal of Cellular Biochemistry 107 460-472. (doi:10.1002/jcb.22144)
63. Xu S, Ogura S, Chen J, Little PJ, Moss J & Liu P 2013 LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cellular and Molecular Life Sciences 70 2859-2872. (doi:10.1007/s00018-012-1194-z)
64. Yokomori H, Yoshimura K, Ohshima S, Nagai T, Fujimaki K, Nomura M, Oda M & Hibi T 2006 The endothelin-1 receptor-mediated pathway is not involved in the endothelin-1-induced defenestration of liver sinusoidal endothelial cells. Liver International 26 1268-1276. (doi:10.1111/j.1478-3231.2006.01365.x)
65. Yokomori H, Oda M, Yoshimura K, Nagai T, Fujimaki K, Watanabe S & Hibi T 2009 Caveolin-1 and Rac regulate endothelial capillary-like tubular formation and fenestral contraction in sinusoidal endothelial cells. Liver International 29 266-276. (doi:10.1111/j.1478-3231.2008.01891.x)
66. Yokomori H, Oda M, Yoshimura K & Hibi T 2012 Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry. Micron 43 129-134. (doi:10.1016/j.micron.2011.08.002)
67. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T & Sawamura T 2011 The discovery of LOX-1, its ligands and clinical significance. Cardiovascular Drugs and Therapy 25 379-391. (doi:10.1007/s10557-011-6324-6)
68. Zabirnyk O, Liu W, Khalil S, Sharma A & Phang JM 2010 Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis 31 446-454. (doi:10.1093/carcin/bgp299)
69. Zhou J, Jia WP, Bao YQ, Ma XJ, Lu W, Yu M, Pan JM, Hu C & Xiang KS 2007 Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 87 2249-2252.
70. Zhou J, Abid MD, Xiong Y & Chen Q 2013 Ox-LDL downregulates eNOS activity via LOX-1-mediated endoplasmic reticulum stress. International Journal of Molecular Medicine 32 1442-1450. (doi:10.3892/ijmm.2013.1513)
71. Zmijewski JW, Moellering DR, Le Goffe C, Landar A, Ramachandran A & Darley-Usmar VM 2005 Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 289 H852-H861. (doi:10.1152/ajpheart.00015.2005)